nodes	percent_of_prediction	percent_of_DWPC	metapath
Bumetanide—Indapamide—Oxcarbazepine—epilepsy syndrome	0.187	1	CrCrCtD
Bumetanide—SLC12A5—epilepsy syndrome	0.157	0.48	CbGaD
Bumetanide—SLC12A2—epilepsy syndrome	0.0767	0.235	CbGaD
Bumetanide—SLCO1A2—epilepsy syndrome	0.0423	0.13	CbGaD
Bumetanide—CA4—epilepsy syndrome	0.042	0.129	CbGaD
Bumetanide—CA14—Lacosamide—epilepsy syndrome	0.0235	0.0741	CbGbCtD
Bumetanide—CA5B—Lacosamide—epilepsy syndrome	0.0195	0.0613	CbGbCtD
Bumetanide—CA9—Lacosamide—epilepsy syndrome	0.0167	0.0526	CbGbCtD
Bumetanide—CA14—Acetazolamide—epilepsy syndrome	0.0162	0.051	CbGbCtD
Bumetanide—CA5A—Acetazolamide—epilepsy syndrome	0.0154	0.0484	CbGbCtD
Bumetanide—CA14—Zonisamide—epilepsy syndrome	0.015	0.0472	CbGbCtD
Bumetanide—CA4—Lacosamide—epilepsy syndrome	0.0147	0.0463	CbGbCtD
Bumetanide—CA5A—Zonisamide—epilepsy syndrome	0.0142	0.0448	CbGbCtD
Bumetanide—CA5B—Acetazolamide—epilepsy syndrome	0.0134	0.0422	CbGbCtD
Bumetanide—CA7—Acetazolamide—epilepsy syndrome	0.0134	0.0422	CbGbCtD
Bumetanide—CA7—Zonisamide—epilepsy syndrome	0.0124	0.039	CbGbCtD
Bumetanide—CA5B—Zonisamide—epilepsy syndrome	0.0124	0.039	CbGbCtD
Bumetanide—CA9—Acetazolamide—epilepsy syndrome	0.0115	0.0362	CbGbCtD
Bumetanide—CA12—Acetazolamide—epilepsy syndrome	0.0115	0.0362	CbGbCtD
Bumetanide—CA9—Zonisamide—epilepsy syndrome	0.0106	0.0335	CbGbCtD
Bumetanide—CA12—Zonisamide—epilepsy syndrome	0.0106	0.0335	CbGbCtD
Bumetanide—CA5A—Topiramate—epilepsy syndrome	0.0104	0.0326	CbGbCtD
Bumetanide—CA4—Acetazolamide—epilepsy syndrome	0.0101	0.0318	CbGbCtD
Bumetanide—CA4—Zonisamide—epilepsy syndrome	0.00936	0.0295	CbGbCtD
Bumetanide—CA5B—Topiramate—epilepsy syndrome	0.00903	0.0284	CbGbCtD
Bumetanide—CA7—Topiramate—epilepsy syndrome	0.00903	0.0284	CbGbCtD
Bumetanide—PTGS2—epilepsy syndrome	0.00876	0.0268	CbGaD
Bumetanide—CA12—Topiramate—epilepsy syndrome	0.00775	0.0244	CbGbCtD
Bumetanide—CA9—Topiramate—epilepsy syndrome	0.00775	0.0244	CbGbCtD
Bumetanide—CA4—Topiramate—epilepsy syndrome	0.00682	0.0215	CbGbCtD
Bumetanide—SLC22A7—Valproic Acid—epilepsy syndrome	0.00628	0.0198	CbGbCtD
Bumetanide—SLC22A8—Valproic Acid—epilepsy syndrome	0.00384	0.0121	CbGbCtD
Bumetanide—SLC22A6—Acetazolamide—epilepsy syndrome	0.00358	0.0113	CbGbCtD
Bumetanide—SLC22A6—Valproic Acid—epilepsy syndrome	0.00267	0.00842	CbGbCtD
Bumetanide—SLC12A5—ganglion—epilepsy syndrome	0.0017	0.058	CbGeAlD
Bumetanide—SLC12A5—hindbrain—epilepsy syndrome	0.00129	0.044	CbGeAlD
Bumetanide—SLC12A4—hindbrain—epilepsy syndrome	0.00107	0.0365	CbGeAlD
Bumetanide—SLC12A1—ganglion—epilepsy syndrome	0.000818	0.0279	CbGeAlD
Bumetanide—SLC12A5—brainstem—epilepsy syndrome	0.00074	0.0252	CbGeAlD
Bumetanide—SLC12A5—forebrain—epilepsy syndrome	0.000714	0.0243	CbGeAlD
Bumetanide—SLC12A5—telencephalon—epilepsy syndrome	0.000657	0.0224	CbGeAlD
Bumetanide—SLC12A4—brainstem—epilepsy syndrome	0.000615	0.0209	CbGeAlD
Bumetanide—SLC12A4—forebrain—epilepsy syndrome	0.000593	0.0202	CbGeAlD
Bumetanide—SLC12A4—telencephalon—epilepsy syndrome	0.000545	0.0186	CbGeAlD
Bumetanide—SLC12A5—medulla oblongata—epilepsy syndrome	0.000516	0.0176	CbGeAlD
Bumetanide—SLC12A5—midbrain—epilepsy syndrome	0.000472	0.0161	CbGeAlD
Bumetanide—SLC12A5—spinal cord—epilepsy syndrome	0.00046	0.0157	CbGeAlD
Bumetanide—Furosemide—CA4—epilepsy syndrome	0.000441	0.25	CrCbGaD
Bumetanide—CA4—ganglion—epilepsy syndrome	0.00044	0.015	CbGeAlD
Bumetanide—SLC12A2—brainstem—epilepsy syndrome	0.000424	0.0145	CbGeAlD
Bumetanide—SLC12A2—forebrain—epilepsy syndrome	0.000409	0.0139	CbGeAlD
Bumetanide—SLC12A5—head—epilepsy syndrome	0.000409	0.0139	CbGeAlD
Bumetanide—SLC12A4—midbrain—epilepsy syndrome	0.000392	0.0133	CbGeAlD
Bumetanide—SLC12A5—nervous system—epilepsy syndrome	0.000388	0.0132	CbGeAlD
Bumetanide—SLC12A4—spinal cord—epilepsy syndrome	0.000382	0.013	CbGeAlD
Bumetanide—Indapamide—CA4—epilepsy syndrome	0.00038	0.216	CrCbGaD
Bumetanide—SLC12A2—telencephalon—epilepsy syndrome	0.000376	0.0128	CbGeAlD
Bumetanide—SLC12A5—central nervous system—epilepsy syndrome	0.000373	0.0127	CbGeAlD
Bumetanide—SLC12A5—cerebellum—epilepsy syndrome	0.000365	0.0124	CbGeAlD
Bumetanide—CA14—telencephalon—epilepsy syndrome	0.000352	0.012	CbGeAlD
Bumetanide—SLC12A1—forebrain—epilepsy syndrome	0.000343	0.0117	CbGeAlD
Bumetanide—SLC12A4—head—epilepsy syndrome	0.00034	0.0116	CbGeAlD
Bumetanide—CA4—hindbrain—epilepsy syndrome	0.000334	0.0114	CbGeAlD
Bumetanide—SLC12A4—nervous system—epilepsy syndrome	0.000322	0.011	CbGeAlD
Bumetanide—SLC12A1—telencephalon—epilepsy syndrome	0.000316	0.0108	CbGeAlD
Bumetanide—SLC12A4—central nervous system—epilepsy syndrome	0.00031	0.0106	CbGeAlD
Bumetanide—SLC12A4—cerebellum—epilepsy syndrome	0.000303	0.0103	CbGeAlD
Bumetanide—CA7—midbrain—epilepsy syndrome	0.000303	0.0103	CbGeAlD
Bumetanide—CA12—forebrain—epilepsy syndrome	0.000298	0.0102	CbGeAlD
Bumetanide—SLC12A5—brain—epilepsy syndrome	0.000296	0.0101	CbGeAlD
Bumetanide—SLC12A2—medulla oblongata—epilepsy syndrome	0.000296	0.0101	CbGeAlD
Bumetanide—CA14—medulla oblongata—epilepsy syndrome	0.000276	0.00941	CbGeAlD
Bumetanide—CA12—telencephalon—epilepsy syndrome	0.000274	0.00934	CbGeAlD
Bumetanide—SLC12A2—midbrain—epilepsy syndrome	0.00027	0.00921	CbGeAlD
Bumetanide—CFTR—head—epilepsy syndrome	0.000267	0.00909	CbGeAlD
Bumetanide—SLC12A2—spinal cord—epilepsy syndrome	0.000264	0.00899	CbGeAlD
Bumetanide—CA14—midbrain—epilepsy syndrome	0.000252	0.0086	CbGeAlD
Bumetanide—CA14—spinal cord—epilepsy syndrome	0.000246	0.00839	CbGeAlD
Bumetanide—SLC12A4—brain—epilepsy syndrome	0.000246	0.00839	CbGeAlD
Bumetanide—CA7—cerebellum—epilepsy syndrome	0.000234	0.00799	CbGeAlD
Bumetanide—SLC12A2—head—epilepsy syndrome	0.000234	0.00799	CbGeAlD
Bumetanide—Tamsulosin—HTR7—epilepsy syndrome	0.000225	0.128	CrCbGaD
Bumetanide—SLC12A2—nervous system—epilepsy syndrome	0.000222	0.00757	CbGeAlD
Bumetanide—SLC10A1—head—epilepsy syndrome	0.000221	0.00755	CbGeAlD
Bumetanide—SLC12A1—spinal cord—epilepsy syndrome	0.000221	0.00753	CbGeAlD
Bumetanide—SLC12A2—central nervous system—epilepsy syndrome	0.000214	0.00729	CbGeAlD
Bumetanide—Furosemide—ABCC2—epilepsy syndrome	0.000213	0.121	CrCbGaD
Bumetanide—SLC10A1—nervous system—epilepsy syndrome	0.00021	0.00715	CbGeAlD
Bumetanide—SLC12A2—cerebellum—epilepsy syndrome	0.000209	0.00712	CbGeAlD
Bumetanide—SLCO1A2—forebrain—epilepsy syndrome	0.000209	0.00711	CbGeAlD
Bumetanide—CA9—cerebellum—epilepsy syndrome	0.000206	0.00702	CbGeAlD
Bumetanide—SLC10A1—central nervous system—epilepsy syndrome	0.000202	0.00689	CbGeAlD
Bumetanide—SLC12A1—head—epilepsy syndrome	0.000197	0.0067	CbGeAlD
Bumetanide—CA14—cerebellum—epilepsy syndrome	0.000195	0.00665	CbGeAlD
Bumetanide—CFTR—brain—epilepsy syndrome	0.000193	0.00659	CbGeAlD
Bumetanide—Tamsulosin—ADRA2A—epilepsy syndrome	0.000193	0.109	CrCbGaD
Bumetanide—SLCO1A2—telencephalon—epilepsy syndrome	0.000192	0.00654	CbGeAlD
Bumetanide—CA4—brainstem—epilepsy syndrome	0.000191	0.00652	CbGeAlD
Bumetanide—CA7—brain—epilepsy syndrome	0.00019	0.00649	CbGeAlD
Bumetanide—SLC12A1—nervous system—epilepsy syndrome	0.000186	0.00635	CbGeAlD
Bumetanide—CA4—forebrain—epilepsy syndrome	0.000185	0.00629	CbGeAlD
Bumetanide—SLC12A1—central nervous system—epilepsy syndrome	0.000179	0.00611	CbGeAlD
Bumetanide—CA12—head—epilepsy syndrome	0.000171	0.00582	CbGeAlD
Bumetanide—SLC12A2—brain—epilepsy syndrome	0.00017	0.00579	CbGeAlD
Bumetanide—CA4—telencephalon—epilepsy syndrome	0.00017	0.00578	CbGeAlD
Bumetanide—CA12—nervous system—epilepsy syndrome	0.000162	0.00551	CbGeAlD
Bumetanide—SLC10A1—brain—epilepsy syndrome	0.00016	0.00547	CbGeAlD
Bumetanide—CA14—brain—epilepsy syndrome	0.000159	0.0054	CbGeAlD
Bumetanide—CA12—central nervous system—epilepsy syndrome	0.000156	0.00531	CbGeAlD
Bumetanide—CA5B—head—epilepsy syndrome	0.000153	0.00522	CbGeAlD
Bumetanide—SLCO1A2—medulla oblongata—epilepsy syndrome	0.000151	0.00514	CbGeAlD
Bumetanide—CA5B—nervous system—epilepsy syndrome	0.000145	0.00495	CbGeAlD
Bumetanide—SLC22A7—brain—epilepsy syndrome	0.000143	0.00487	CbGeAlD
Bumetanide—SLC12A1—brain—epilepsy syndrome	0.000142	0.00485	CbGeAlD
Bumetanide—CA5B—central nervous system—epilepsy syndrome	0.00014	0.00476	CbGeAlD
Bumetanide—SLC22A6—brain—epilepsy syndrome	0.000138	0.00471	CbGeAlD
Bumetanide—SLCO1A2—midbrain—epilepsy syndrome	0.000138	0.00469	CbGeAlD
Bumetanide—SLCO1A2—spinal cord—epilepsy syndrome	0.000134	0.00458	CbGeAlD
Bumetanide—CA4—medulla oblongata—epilepsy syndrome	0.000133	0.00454	CbGeAlD
Bumetanide—CA12—brain—epilepsy syndrome	0.000124	0.00421	CbGeAlD
Bumetanide—CA4—midbrain—epilepsy syndrome	0.000122	0.00415	CbGeAlD
Bumetanide—SLCO1A2—head—epilepsy syndrome	0.000119	0.00407	CbGeAlD
Bumetanide—CA4—spinal cord—epilepsy syndrome	0.000119	0.00405	CbGeAlD
Bumetanide—SLC22A8—head—epilepsy syndrome	0.000114	0.00389	CbGeAlD
Bumetanide—SLCO1A2—nervous system—epilepsy syndrome	0.000113	0.00386	CbGeAlD
Bumetanide—PTGS2—forebrain—epilepsy syndrome	0.000113	0.00385	CbGeAlD
Bumetanide—CA5B—brain—epilepsy syndrome	0.000111	0.00378	CbGeAlD
Bumetanide—SLCO1A2—central nervous system—epilepsy syndrome	0.000109	0.00372	CbGeAlD
Bumetanide—SLC22A8—nervous system—epilepsy syndrome	0.000108	0.00369	CbGeAlD
Bumetanide—SLCO1A2—cerebellum—epilepsy syndrome	0.000107	0.00363	CbGeAlD
Bumetanide—CA4—head—epilepsy syndrome	0.000106	0.0036	CbGeAlD
Bumetanide—SLC22A8—central nervous system—epilepsy syndrome	0.000104	0.00355	CbGeAlD
Bumetanide—PTGS2—telencephalon—epilepsy syndrome	0.000104	0.00354	CbGeAlD
Bumetanide—Tamsulosin—CYP2D6—epilepsy syndrome	0.000103	0.0586	CrCbGaD
Bumetanide—CA4—nervous system—epilepsy syndrome	0.0001	0.00341	CbGeAlD
Bumetanide—CA4—central nervous system—epilepsy syndrome	9.65e-05	0.00329	CbGeAlD
Bumetanide—CA4—cerebellum—epilepsy syndrome	9.43e-05	0.00321	CbGeAlD
Bumetanide—SLCO1A2—brain—epilepsy syndrome	8.66e-05	0.00295	CbGeAlD
Bumetanide—SLC22A8—brain—epilepsy syndrome	8.27e-05	0.00282	CbGeAlD
Bumetanide—Furosemide—ALB—epilepsy syndrome	8.19e-05	0.0465	CrCbGaD
Bumetanide—PTGS2—medulla oblongata—epilepsy syndrome	8.16e-05	0.00278	CbGeAlD
Bumetanide—CA4—brain—epilepsy syndrome	7.66e-05	0.00261	CbGeAlD
Bumetanide—PTGS2—midbrain—epilepsy syndrome	7.46e-05	0.00254	CbGeAlD
Bumetanide—PTGS2—spinal cord—epilepsy syndrome	7.28e-05	0.00248	CbGeAlD
Bumetanide—Fenoprofen—PTGS2—epilepsy syndrome	6.6e-05	0.0375	CrCbGaD
Bumetanide—PTGS2—head—epilepsy syndrome	6.47e-05	0.0022	CbGeAlD
Bumetanide—PTGS2—nervous system—epilepsy syndrome	6.13e-05	0.00209	CbGeAlD
Bumetanide—Thrombocytopenia—Lamotrigine—epilepsy syndrome	6.13e-05	0.00083	CcSEcCtD
Bumetanide—Gastrointestinal pain—Diazepam—epilepsy syndrome	6.12e-05	0.000828	CcSEcCtD
Bumetanide—Fatigue—Zonisamide—epilepsy syndrome	6.12e-05	0.000827	CcSEcCtD
Bumetanide—Hypotension—Carbamazepine—epilepsy syndrome	6.06e-05	0.000819	CcSEcCtD
Bumetanide—Hyperhidrosis—Lamotrigine—epilepsy syndrome	6.06e-05	0.000819	CcSEcCtD
Bumetanide—Urticaria—Vigabatrin—epilepsy syndrome	6.04e-05	0.000817	CcSEcCtD
Bumetanide—Abdominal pain—Vigabatrin—epilepsy syndrome	6.01e-05	0.000813	CcSEcCtD
Bumetanide—Nausea—Clobazam—epilepsy syndrome	6e-05	0.000812	CcSEcCtD
Bumetanide—Asthenia—Propofol—epilepsy syndrome	6e-05	0.000812	CcSEcCtD
Bumetanide—Erythema multiforme—Pregabalin—epilepsy syndrome	5.99e-05	0.00081	CcSEcCtD
Bumetanide—Pancreatitis—Topiramate—epilepsy syndrome	5.99e-05	0.00081	CcSEcCtD
Bumetanide—Dizziness—Acetazolamide—epilepsy syndrome	5.96e-05	0.000806	CcSEcCtD
Bumetanide—Urticaria—Diazepam—epilepsy syndrome	5.95e-05	0.000804	CcSEcCtD
Bumetanide—Gastrointestinal pain—Felbamate—epilepsy syndrome	5.93e-05	0.000801	CcSEcCtD
Bumetanide—Pruritus—Propofol—epilepsy syndrome	5.92e-05	0.000801	CcSEcCtD
Bumetanide—Abdominal pain—Diazepam—epilepsy syndrome	5.92e-05	0.000801	CcSEcCtD
Bumetanide—PTGS2—central nervous system—epilepsy syndrome	5.91e-05	0.00201	CbGeAlD
Bumetanide—Fatigue—Clonazepam—epilepsy syndrome	5.89e-05	0.000797	CcSEcCtD
Bumetanide—Fenoprofen—ALB—epilepsy syndrome	5.88e-05	0.0334	CrCbGaD
Bumetanide—Asthenia—Midazolam—epilepsy syndrome	5.87e-05	0.000794	CcSEcCtD
Bumetanide—Muscle spasms—Valproic Acid—epilepsy syndrome	5.86e-05	0.000793	CcSEcCtD
Bumetanide—Fatigue—Phenytoin—epilepsy syndrome	5.85e-05	0.000792	CcSEcCtD
Bumetanide—Abdominal discomfort—Topiramate—epilepsy syndrome	5.85e-05	0.000792	CcSEcCtD
Bumetanide—Fatigue—Oxcarbazepine—epilepsy syndrome	5.82e-05	0.000788	CcSEcCtD
Bumetanide—Gastrointestinal pain—Zonisamide—epilepsy syndrome	5.8e-05	0.000785	CcSEcCtD
Bumetanide—Asthenia—Levetiracetam—epilepsy syndrome	5.8e-05	0.000784	CcSEcCtD
Bumetanide—Pruritus—Midazolam—epilepsy syndrome	5.79e-05	0.000783	CcSEcCtD
Bumetanide—PTGS2—cerebellum—epilepsy syndrome	5.77e-05	0.00197	CbGeAlD
Bumetanide—Urticaria—Felbamate—epilepsy syndrome	5.76e-05	0.000779	CcSEcCtD
Bumetanide—Abdominal pain—Felbamate—epilepsy syndrome	5.73e-05	0.000775	CcSEcCtD
Bumetanide—Vomiting—Acetazolamide—epilepsy syndrome	5.73e-05	0.000775	CcSEcCtD
Bumetanide—Diarrhoea—Propofol—epilepsy syndrome	5.72e-05	0.000774	CcSEcCtD
Bumetanide—Pruritus—Levetiracetam—epilepsy syndrome	5.72e-05	0.000774	CcSEcCtD
Bumetanide—Headache—Acetazolamide—epilepsy syndrome	5.64e-05	0.000763	CcSEcCtD
Bumetanide—Urticaria—Zonisamide—epilepsy syndrome	5.64e-05	0.000762	CcSEcCtD
Bumetanide—Abdominal pain—Zonisamide—epilepsy syndrome	5.61e-05	0.000758	CcSEcCtD
Bumetanide—Asthenia—Fosphenytoin—epilepsy syndrome	5.6e-05	0.000757	CcSEcCtD
Bumetanide—Gastrointestinal pain—Clonazepam—epilepsy syndrome	5.59e-05	0.000756	CcSEcCtD
Bumetanide—Fatigue—Carbamazepine—epilepsy syndrome	5.59e-05	0.000756	CcSEcCtD
Bumetanide—Dizziness—Propofol—epilepsy syndrome	5.53e-05	0.000748	CcSEcCtD
Bumetanide—Diarrhoea—Levetiracetam—epilepsy syndrome	5.53e-05	0.000748	CcSEcCtD
Bumetanide—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	5.52e-05	0.000747	CcSEcCtD
Bumetanide—Pruritus—Fosphenytoin—epilepsy syndrome	5.52e-05	0.000747	CcSEcCtD
Bumetanide—Hyperglycaemia—Topiramate—epilepsy syndrome	5.51e-05	0.000745	CcSEcCtD
Bumetanide—Erythema multiforme—Gabapentin—epilepsy syndrome	5.49e-05	0.000743	CcSEcCtD
Bumetanide—Vertigo—Valproic Acid—epilepsy syndrome	5.48e-05	0.000741	CcSEcCtD
Bumetanide—Leukopenia—Valproic Acid—epilepsy syndrome	5.46e-05	0.000738	CcSEcCtD
Bumetanide—Asthenia—Vigabatrin—epilepsy syndrome	5.46e-05	0.000738	CcSEcCtD
Bumetanide—Urticaria—Clonazepam—epilepsy syndrome	5.43e-05	0.000735	CcSEcCtD
Bumetanide—Dizziness—Midazolam—epilepsy syndrome	5.41e-05	0.000732	CcSEcCtD
Bumetanide—Abdominal pain—Clonazepam—epilepsy syndrome	5.4e-05	0.000731	CcSEcCtD
Bumetanide—Fatigue—Lamotrigine—epilepsy syndrome	5.4e-05	0.00073	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Topiramate—epilepsy syndrome	5.4e-05	0.00073	CcSEcCtD
Bumetanide—Urticaria—Phenytoin—epilepsy syndrome	5.39e-05	0.00073	CcSEcCtD
Bumetanide—Pruritus—Vigabatrin—epilepsy syndrome	5.38e-05	0.000728	CcSEcCtD
Bumetanide—Asthenia—Diazepam—epilepsy syndrome	5.37e-05	0.000727	CcSEcCtD
Bumetanide—Urticaria—Oxcarbazepine—epilepsy syndrome	5.37e-05	0.000726	CcSEcCtD
Bumetanide—Renal failure—Topiramate—epilepsy syndrome	5.35e-05	0.000724	CcSEcCtD
Bumetanide—Nausea—Acetazolamide—epilepsy syndrome	5.35e-05	0.000724	CcSEcCtD
Bumetanide—Dizziness—Levetiracetam—epilepsy syndrome	5.35e-05	0.000723	CcSEcCtD
Bumetanide—Abdominal pain—Oxcarbazepine—epilepsy syndrome	5.34e-05	0.000722	CcSEcCtD
Bumetanide—Diarrhoea—Fosphenytoin—epilepsy syndrome	5.34e-05	0.000722	CcSEcCtD
Bumetanide—Vomiting—Propofol—epilepsy syndrome	5.32e-05	0.00072	CcSEcCtD
Bumetanide—Muscle spasms—Pregabalin—epilepsy syndrome	5.3e-05	0.000717	CcSEcCtD
Bumetanide—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	5.3e-05	0.000717	CcSEcCtD
Bumetanide—Pruritus—Diazepam—epilepsy syndrome	5.3e-05	0.000716	CcSEcCtD
Bumetanide—Rash—Propofol—epilepsy syndrome	5.28e-05	0.000714	CcSEcCtD
Bumetanide—Dermatitis—Propofol—epilepsy syndrome	5.27e-05	0.000713	CcSEcCtD
Bumetanide—Headache—Propofol—epilepsy syndrome	5.24e-05	0.000709	CcSEcCtD
Bumetanide—Vomiting—Midazolam—epilepsy syndrome	5.21e-05	0.000704	CcSEcCtD
Bumetanide—Diarrhoea—Vigabatrin—epilepsy syndrome	5.2e-05	0.000704	CcSEcCtD
Bumetanide—Asthenia—Felbamate—epilepsy syndrome	5.2e-05	0.000703	CcSEcCtD
Bumetanide—Arthralgia—Valproic Acid—epilepsy syndrome	5.19e-05	0.000702	CcSEcCtD
Bumetanide—Chest pain—Valproic Acid—epilepsy syndrome	5.19e-05	0.000702	CcSEcCtD
Bumetanide—Rash—Midazolam—epilepsy syndrome	5.16e-05	0.000698	CcSEcCtD
Bumetanide—Dizziness—Fosphenytoin—epilepsy syndrome	5.16e-05	0.000698	CcSEcCtD
Bumetanide—Dermatitis—Midazolam—epilepsy syndrome	5.16e-05	0.000697	CcSEcCtD
Bumetanide—Urticaria—Carbamazepine—epilepsy syndrome	5.15e-05	0.000696	CcSEcCtD
Bumetanide—Vomiting—Levetiracetam—epilepsy syndrome	5.14e-05	0.000695	CcSEcCtD
Bumetanide—Headache—Midazolam—epilepsy syndrome	5.13e-05	0.000694	CcSEcCtD
Bumetanide—Pruritus—Felbamate—epilepsy syndrome	5.13e-05	0.000693	CcSEcCtD
Bumetanide—Abdominal pain—Carbamazepine—epilepsy syndrome	5.12e-05	0.000693	CcSEcCtD
Bumetanide—Diarrhoea—Diazepam—epilepsy syndrome	5.12e-05	0.000693	CcSEcCtD
Bumetanide—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	5.12e-05	0.000693	CcSEcCtD
Bumetanide—Rash—Levetiracetam—epilepsy syndrome	5.1e-05	0.000689	CcSEcCtD
Bumetanide—Dermatitis—Levetiracetam—epilepsy syndrome	5.09e-05	0.000689	CcSEcCtD
Bumetanide—Asthenia—Zonisamide—epilepsy syndrome	5.09e-05	0.000688	CcSEcCtD
Bumetanide—Dry mouth—Valproic Acid—epilepsy syndrome	5.08e-05	0.000687	CcSEcCtD
Bumetanide—Headache—Levetiracetam—epilepsy syndrome	5.06e-05	0.000685	CcSEcCtD
Bumetanide—Dizziness—Vigabatrin—epilepsy syndrome	5.03e-05	0.00068	CcSEcCtD
Bumetanide—Pruritus—Zonisamide—epilepsy syndrome	5.02e-05	0.000679	CcSEcCtD
Bumetanide—Urticaria—Lamotrigine—epilepsy syndrome	4.98e-05	0.000673	CcSEcCtD
Bumetanide—Nausea—Propofol—epilepsy syndrome	4.97e-05	0.000672	CcSEcCtD
Bumetanide—Vomiting—Fosphenytoin—epilepsy syndrome	4.96e-05	0.000671	CcSEcCtD
Bumetanide—Diarrhoea—Felbamate—epilepsy syndrome	4.96e-05	0.000671	CcSEcCtD
Bumetanide—Vertigo—Pregabalin—epilepsy syndrome	4.95e-05	0.00067	CcSEcCtD
Bumetanide—Abdominal pain—Lamotrigine—epilepsy syndrome	4.95e-05	0.00067	CcSEcCtD
Bumetanide—Dizziness—Diazepam—epilepsy syndrome	4.95e-05	0.00067	CcSEcCtD
Bumetanide—Leukopenia—Pregabalin—epilepsy syndrome	4.94e-05	0.000668	CcSEcCtD
Bumetanide—Rash—Fosphenytoin—epilepsy syndrome	4.92e-05	0.000665	CcSEcCtD
Bumetanide—Dermatitis—Fosphenytoin—epilepsy syndrome	4.91e-05	0.000665	CcSEcCtD
Bumetanide—Asthenia—Clonazepam—epilepsy syndrome	4.9e-05	0.000663	CcSEcCtD
Bumetanide—Headache—Fosphenytoin—epilepsy syndrome	4.89e-05	0.000661	CcSEcCtD
Bumetanide—Thrombocytopenia—Valproic Acid—epilepsy syndrome	4.87e-05	0.000659	CcSEcCtD
Bumetanide—Asthenia—Phenytoin—epilepsy syndrome	4.87e-05	0.000659	CcSEcCtD
Bumetanide—Nausea—Midazolam—epilepsy syndrome	4.86e-05	0.000658	CcSEcCtD
Bumetanide—Muscle spasms—Gabapentin—epilepsy syndrome	4.86e-05	0.000657	CcSEcCtD
Bumetanide—Diarrhoea—Zonisamide—epilepsy syndrome	4.85e-05	0.000656	CcSEcCtD
Bumetanide—Asthenia—Oxcarbazepine—epilepsy syndrome	4.85e-05	0.000655	CcSEcCtD
Bumetanide—Pruritus—Clonazepam—epilepsy syndrome	4.84e-05	0.000654	CcSEcCtD
Bumetanide—Vomiting—Vigabatrin—epilepsy syndrome	4.84e-05	0.000654	CcSEcCtD
Bumetanide—Hyperhidrosis—Valproic Acid—epilepsy syndrome	4.81e-05	0.000651	CcSEcCtD
Bumetanide—Pruritus—Phenytoin—epilepsy syndrome	4.8e-05	0.00065	CcSEcCtD
Bumetanide—Nausea—Levetiracetam—epilepsy syndrome	4.8e-05	0.000649	CcSEcCtD
Bumetanide—Rash—Vigabatrin—epilepsy syndrome	4.8e-05	0.000649	CcSEcCtD
Bumetanide—Dizziness—Felbamate—epilepsy syndrome	4.79e-05	0.000648	CcSEcCtD
Bumetanide—Dermatitis—Vigabatrin—epilepsy syndrome	4.79e-05	0.000648	CcSEcCtD
Bumetanide—Pruritus—Oxcarbazepine—epilepsy syndrome	4.78e-05	0.000646	CcSEcCtD
Bumetanide—Headache—Vigabatrin—epilepsy syndrome	4.76e-05	0.000644	CcSEcCtD
Bumetanide—Vomiting—Diazepam—epilepsy syndrome	4.76e-05	0.000644	CcSEcCtD
Bumetanide—Rash—Diazepam—epilepsy syndrome	4.72e-05	0.000638	CcSEcCtD
Bumetanide—Dermatitis—Diazepam—epilepsy syndrome	4.72e-05	0.000638	CcSEcCtD
Bumetanide—Chest pain—Pregabalin—epilepsy syndrome	4.69e-05	0.000635	CcSEcCtD
Bumetanide—Arthralgia—Pregabalin—epilepsy syndrome	4.69e-05	0.000635	CcSEcCtD
Bumetanide—Dizziness—Zonisamide—epilepsy syndrome	4.69e-05	0.000634	CcSEcCtD
Bumetanide—Headache—Diazepam—epilepsy syndrome	4.69e-05	0.000634	CcSEcCtD
Bumetanide—PTGS2—brain—epilepsy syndrome	4.69e-05	0.0016	CbGeAlD
Bumetanide—Diarrhoea—Clonazepam—epilepsy syndrome	4.68e-05	0.000633	CcSEcCtD
Bumetanide—Hypotension—Valproic Acid—epilepsy syndrome	4.65e-05	0.000629	CcSEcCtD
Bumetanide—Asthenia—Carbamazepine—epilepsy syndrome	4.65e-05	0.000629	CcSEcCtD
Bumetanide—Diarrhoea—Phenytoin—epilepsy syndrome	4.65e-05	0.000628	CcSEcCtD
Bumetanide—Nausea—Fosphenytoin—epilepsy syndrome	4.63e-05	0.000627	CcSEcCtD
Bumetanide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.62e-05	0.000625	CcSEcCtD
Bumetanide—Erythema multiforme—Topiramate—epilepsy syndrome	4.62e-05	0.000625	CcSEcCtD
Bumetanide—Vomiting—Felbamate—epilepsy syndrome	4.61e-05	0.000623	CcSEcCtD
Bumetanide—Dry mouth—Pregabalin—epilepsy syndrome	4.59e-05	0.000621	CcSEcCtD
Bumetanide—Pruritus—Carbamazepine—epilepsy syndrome	4.59e-05	0.00062	CcSEcCtD
Bumetanide—Rash—Felbamate—epilepsy syndrome	4.57e-05	0.000618	CcSEcCtD
Bumetanide—Dermatitis—Felbamate—epilepsy syndrome	4.56e-05	0.000617	CcSEcCtD
Bumetanide—Vertigo—Gabapentin—epilepsy syndrome	4.54e-05	0.000614	CcSEcCtD
Bumetanide—Headache—Felbamate—epilepsy syndrome	4.54e-05	0.000614	CcSEcCtD
Bumetanide—Leukopenia—Gabapentin—epilepsy syndrome	4.53e-05	0.000612	CcSEcCtD
Bumetanide—Dizziness—Clonazepam—epilepsy syndrome	4.52e-05	0.000611	CcSEcCtD
Bumetanide—Nausea—Vigabatrin—epilepsy syndrome	4.52e-05	0.000611	CcSEcCtD
Bumetanide—Vomiting—Zonisamide—epilepsy syndrome	4.51e-05	0.00061	CcSEcCtD
Bumetanide—Asthenia—Lamotrigine—epilepsy syndrome	4.49e-05	0.000608	CcSEcCtD
Bumetanide—Dizziness—Phenytoin—epilepsy syndrome	4.49e-05	0.000607	CcSEcCtD
Bumetanide—Rash—Zonisamide—epilepsy syndrome	4.47e-05	0.000605	CcSEcCtD
Bumetanide—Dermatitis—Zonisamide—epilepsy syndrome	4.47e-05	0.000604	CcSEcCtD
Bumetanide—Dizziness—Oxcarbazepine—epilepsy syndrome	4.47e-05	0.000604	CcSEcCtD
Bumetanide—Nausea—Diazepam—epilepsy syndrome	4.45e-05	0.000602	CcSEcCtD
Bumetanide—Headache—Zonisamide—epilepsy syndrome	4.44e-05	0.000601	CcSEcCtD
Bumetanide—Diarrhoea—Carbamazepine—epilepsy syndrome	4.43e-05	0.0006	CcSEcCtD
Bumetanide—Pruritus—Lamotrigine—epilepsy syndrome	4.43e-05	0.000599	CcSEcCtD
Bumetanide—Thrombocytopenia—Pregabalin—epilepsy syndrome	4.41e-05	0.000596	CcSEcCtD
Bumetanide—Hyperhidrosis—Pregabalin—epilepsy syndrome	4.35e-05	0.000588	CcSEcCtD
Bumetanide—Vomiting—Clonazepam—epilepsy syndrome	4.35e-05	0.000588	CcSEcCtD
Bumetanide—Vomiting—Phenytoin—epilepsy syndrome	4.32e-05	0.000584	CcSEcCtD
Bumetanide—Rash—Clonazepam—epilepsy syndrome	4.31e-05	0.000583	CcSEcCtD
Bumetanide—Dermatitis—Clonazepam—epilepsy syndrome	4.31e-05	0.000582	CcSEcCtD
Bumetanide—Arthralgia—Gabapentin—epilepsy syndrome	4.3e-05	0.000582	CcSEcCtD
Bumetanide—Chest pain—Gabapentin—epilepsy syndrome	4.3e-05	0.000582	CcSEcCtD
Bumetanide—Nausea—Felbamate—epilepsy syndrome	4.3e-05	0.000582	CcSEcCtD
Bumetanide—Vomiting—Oxcarbazepine—epilepsy syndrome	4.29e-05	0.000581	CcSEcCtD
Bumetanide—Fatigue—Valproic Acid—epilepsy syndrome	4.29e-05	0.00058	CcSEcCtD
Bumetanide—Dizziness—Carbamazepine—epilepsy syndrome	4.29e-05	0.00058	CcSEcCtD
Bumetanide—Diarrhoea—Lamotrigine—epilepsy syndrome	4.29e-05	0.00058	CcSEcCtD
Bumetanide—Headache—Clonazepam—epilepsy syndrome	4.28e-05	0.000579	CcSEcCtD
Bumetanide—Rash—Phenytoin—epilepsy syndrome	4.28e-05	0.000579	CcSEcCtD
Bumetanide—Dermatitis—Phenytoin—epilepsy syndrome	4.28e-05	0.000579	CcSEcCtD
Bumetanide—Rash—Oxcarbazepine—epilepsy syndrome	4.26e-05	0.000576	CcSEcCtD
Bumetanide—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.26e-05	0.000575	CcSEcCtD
Bumetanide—Headache—Phenytoin—epilepsy syndrome	4.25e-05	0.000575	CcSEcCtD
Bumetanide—Headache—Oxcarbazepine—epilepsy syndrome	4.23e-05	0.000572	CcSEcCtD
Bumetanide—Nausea—Zonisamide—epilepsy syndrome	4.21e-05	0.00057	CcSEcCtD
Bumetanide—Dry mouth—Gabapentin—epilepsy syndrome	4.21e-05	0.000569	CcSEcCtD
Bumetanide—Hypotension—Pregabalin—epilepsy syndrome	4.21e-05	0.000569	CcSEcCtD
Bumetanide—Dizziness—Lamotrigine—epilepsy syndrome	4.14e-05	0.00056	CcSEcCtD
Bumetanide—Vomiting—Carbamazepine—epilepsy syndrome	4.12e-05	0.000557	CcSEcCtD
Bumetanide—Muscle spasms—Topiramate—epilepsy syndrome	4.09e-05	0.000553	CcSEcCtD
Bumetanide—Rash—Carbamazepine—epilepsy syndrome	4.09e-05	0.000553	CcSEcCtD
Bumetanide—Dermatitis—Carbamazepine—epilepsy syndrome	4.08e-05	0.000552	CcSEcCtD
Bumetanide—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.07e-05	0.000551	CcSEcCtD
Bumetanide—Nausea—Clonazepam—epilepsy syndrome	4.06e-05	0.000549	CcSEcCtD
Bumetanide—Headache—Carbamazepine—epilepsy syndrome	4.06e-05	0.000549	CcSEcCtD
Bumetanide—Thrombocytopenia—Gabapentin—epilepsy syndrome	4.04e-05	0.000546	CcSEcCtD
Bumetanide—Nausea—Phenytoin—epilepsy syndrome	4.03e-05	0.000546	CcSEcCtD
Bumetanide—Nausea—Oxcarbazepine—epilepsy syndrome	4.01e-05	0.000543	CcSEcCtD
Bumetanide—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.99e-05	0.00054	CcSEcCtD
Bumetanide—Vomiting—Lamotrigine—epilepsy syndrome	3.98e-05	0.000539	CcSEcCtD
Bumetanide—Urticaria—Valproic Acid—epilepsy syndrome	3.95e-05	0.000535	CcSEcCtD
Bumetanide—Rash—Lamotrigine—epilepsy syndrome	3.95e-05	0.000534	CcSEcCtD
Bumetanide—Dermatitis—Lamotrigine—epilepsy syndrome	3.95e-05	0.000534	CcSEcCtD
Bumetanide—Abdominal pain—Valproic Acid—epilepsy syndrome	3.94e-05	0.000532	CcSEcCtD
Bumetanide—Headache—Lamotrigine—epilepsy syndrome	3.92e-05	0.000531	CcSEcCtD
Bumetanide—Fatigue—Pregabalin—epilepsy syndrome	3.88e-05	0.000525	CcSEcCtD
Bumetanide—Hypotension—Gabapentin—epilepsy syndrome	3.86e-05	0.000522	CcSEcCtD
Bumetanide—Nausea—Carbamazepine—epilepsy syndrome	3.85e-05	0.000521	CcSEcCtD
Bumetanide—Vertigo—Topiramate—epilepsy syndrome	3.82e-05	0.000517	CcSEcCtD
Bumetanide—Leukopenia—Topiramate—epilepsy syndrome	3.81e-05	0.000515	CcSEcCtD
Bumetanide—Nausea—Lamotrigine—epilepsy syndrome	3.72e-05	0.000503	CcSEcCtD
Bumetanide—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.68e-05	0.000498	CcSEcCtD
Bumetanide—Chest pain—Topiramate—epilepsy syndrome	3.62e-05	0.00049	CcSEcCtD
Bumetanide—Arthralgia—Topiramate—epilepsy syndrome	3.62e-05	0.00049	CcSEcCtD
Bumetanide—Urticaria—Pregabalin—epilepsy syndrome	3.58e-05	0.000484	CcSEcCtD
Bumetanide—Asthenia—Valproic Acid—epilepsy syndrome	3.57e-05	0.000483	CcSEcCtD
Bumetanide—Fatigue—Gabapentin—epilepsy syndrome	3.56e-05	0.000481	CcSEcCtD
Bumetanide—Abdominal pain—Pregabalin—epilepsy syndrome	3.56e-05	0.000481	CcSEcCtD
Bumetanide—Dry mouth—Topiramate—epilepsy syndrome	3.54e-05	0.000479	CcSEcCtD
Bumetanide—Pruritus—Valproic Acid—epilepsy syndrome	3.52e-05	0.000476	CcSEcCtD
Bumetanide—Diarrhoea—Valproic Acid—epilepsy syndrome	3.41e-05	0.000461	CcSEcCtD
Bumetanide—Thrombocytopenia—Topiramate—epilepsy syndrome	3.4e-05	0.00046	CcSEcCtD
Bumetanide—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.37e-05	0.000456	CcSEcCtD
Bumetanide—Hyperhidrosis—Topiramate—epilepsy syndrome	3.36e-05	0.000454	CcSEcCtD
Bumetanide—Dizziness—Valproic Acid—epilepsy syndrome	3.29e-05	0.000445	CcSEcCtD
Bumetanide—Urticaria—Gabapentin—epilepsy syndrome	3.28e-05	0.000443	CcSEcCtD
Bumetanide—Abdominal pain—Gabapentin—epilepsy syndrome	3.26e-05	0.000441	CcSEcCtD
Bumetanide—Hypotension—Topiramate—epilepsy syndrome	3.24e-05	0.000439	CcSEcCtD
Bumetanide—Asthenia—Pregabalin—epilepsy syndrome	3.23e-05	0.000437	CcSEcCtD
Bumetanide—Pruritus—Pregabalin—epilepsy syndrome	3.18e-05	0.000431	CcSEcCtD
Bumetanide—Vomiting—Valproic Acid—epilepsy syndrome	3.17e-05	0.000428	CcSEcCtD
Bumetanide—Rash—Valproic Acid—epilepsy syndrome	3.14e-05	0.000425	CcSEcCtD
Bumetanide—Dermatitis—Valproic Acid—epilepsy syndrome	3.14e-05	0.000424	CcSEcCtD
Bumetanide—Headache—Valproic Acid—epilepsy syndrome	3.12e-05	0.000422	CcSEcCtD
Bumetanide—Diarrhoea—Pregabalin—epilepsy syndrome	3.08e-05	0.000416	CcSEcCtD
Bumetanide—Fatigue—Topiramate—epilepsy syndrome	2.99e-05	0.000405	CcSEcCtD
Bumetanide—Dizziness—Pregabalin—epilepsy syndrome	2.98e-05	0.000403	CcSEcCtD
Bumetanide—Asthenia—Gabapentin—epilepsy syndrome	2.96e-05	0.0004	CcSEcCtD
Bumetanide—Nausea—Valproic Acid—epilepsy syndrome	2.96e-05	0.0004	CcSEcCtD
Bumetanide—Pruritus—Gabapentin—epilepsy syndrome	2.92e-05	0.000395	CcSEcCtD
Bumetanide—Vomiting—Pregabalin—epilepsy syndrome	2.86e-05	0.000387	CcSEcCtD
Bumetanide—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.84e-05	0.000384	CcSEcCtD
Bumetanide—Rash—Pregabalin—epilepsy syndrome	2.84e-05	0.000384	CcSEcCtD
Bumetanide—Dermatitis—Pregabalin—epilepsy syndrome	2.83e-05	0.000383	CcSEcCtD
Bumetanide—Diarrhoea—Gabapentin—epilepsy syndrome	2.82e-05	0.000382	CcSEcCtD
Bumetanide—Headache—Pregabalin—epilepsy syndrome	2.82e-05	0.000381	CcSEcCtD
Bumetanide—Urticaria—Topiramate—epilepsy syndrome	2.76e-05	0.000373	CcSEcCtD
Bumetanide—Abdominal pain—Topiramate—epilepsy syndrome	2.74e-05	0.000371	CcSEcCtD
Bumetanide—Dizziness—Gabapentin—epilepsy syndrome	2.73e-05	0.000369	CcSEcCtD
Bumetanide—Nausea—Pregabalin—epilepsy syndrome	2.67e-05	0.000362	CcSEcCtD
Bumetanide—Vomiting—Gabapentin—epilepsy syndrome	2.62e-05	0.000355	CcSEcCtD
Bumetanide—Rash—Gabapentin—epilepsy syndrome	2.6e-05	0.000352	CcSEcCtD
Bumetanide—Dermatitis—Gabapentin—epilepsy syndrome	2.6e-05	0.000352	CcSEcCtD
Bumetanide—Headache—Gabapentin—epilepsy syndrome	2.59e-05	0.00035	CcSEcCtD
Bumetanide—Asthenia—Topiramate—epilepsy syndrome	2.49e-05	0.000337	CcSEcCtD
Bumetanide—Pruritus—Topiramate—epilepsy syndrome	2.46e-05	0.000332	CcSEcCtD
Bumetanide—Nausea—Gabapentin—epilepsy syndrome	2.45e-05	0.000332	CcSEcCtD
Bumetanide—Diarrhoea—Topiramate—epilepsy syndrome	2.38e-05	0.000321	CcSEcCtD
Bumetanide—Dizziness—Topiramate—epilepsy syndrome	2.3e-05	0.000311	CcSEcCtD
Bumetanide—Vomiting—Topiramate—epilepsy syndrome	2.21e-05	0.000299	CcSEcCtD
Bumetanide—Rash—Topiramate—epilepsy syndrome	2.19e-05	0.000296	CcSEcCtD
Bumetanide—Dermatitis—Topiramate—epilepsy syndrome	2.19e-05	0.000296	CcSEcCtD
Bumetanide—Headache—Topiramate—epilepsy syndrome	2.18e-05	0.000294	CcSEcCtD
Bumetanide—Nausea—Topiramate—epilepsy syndrome	2.06e-05	0.000279	CcSEcCtD
Bumetanide—SLCO1A2—Metabolism—ALAD—epilepsy syndrome	4.59e-06	7.22e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—NT5E—epilepsy syndrome	4.59e-06	7.22e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CYP2D6—epilepsy syndrome	4.58e-06	7.21e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—ADRA2A—epilepsy syndrome	4.57e-06	7.2e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	4.56e-06	7.18e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—BCHE—epilepsy syndrome	4.55e-06	7.17e-05	CbGpPWpGaD
Bumetanide—CA7—Metabolism—CAT—epilepsy syndrome	4.55e-06	7.17e-05	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—CAT—epilepsy syndrome	4.55e-06	7.17e-05	CbGpPWpGaD
Bumetanide—CA14—Metabolism—GPX1—epilepsy syndrome	4.52e-06	7.12e-05	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	4.49e-06	7.08e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	4.43e-06	6.98e-05	CbGpPWpGaD
Bumetanide—CA7—Metabolism—ABCB1—epilepsy syndrome	4.43e-06	6.97e-05	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—ABCB1—epilepsy syndrome	4.43e-06	6.97e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PNPO—epilepsy syndrome	4.41e-06	6.95e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—EPM2A—epilepsy syndrome	4.41e-06	6.95e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—NHLRC1—epilepsy syndrome	4.41e-06	6.95e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GAMT—epilepsy syndrome	4.41e-06	6.95e-05	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—GPX1—epilepsy syndrome	4.41e-06	6.94e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ALDH7A1—epilepsy syndrome	4.37e-06	6.89e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CACNA1A—epilepsy syndrome	4.37e-06	6.89e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PFKL—epilepsy syndrome	4.36e-06	6.87e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—ADRA2A—epilepsy syndrome	4.36e-06	6.87e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—BCHE—epilepsy syndrome	4.34e-06	6.84e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—SLC2A1—epilepsy syndrome	4.34e-06	6.84e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PLCB1—epilepsy syndrome	4.29e-06	6.76e-05	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	4.29e-06	6.75e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ST3GAL3—epilepsy syndrome	4.28e-06	6.74e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—TH—epilepsy syndrome	4.28e-06	6.74e-05	CbGpPWpGaD
Bumetanide—CA12—Metabolism—HMOX1—epilepsy syndrome	4.27e-06	6.73e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ABCG2—epilepsy syndrome	4.23e-06	6.67e-05	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	4.23e-06	6.65e-05	CbGpPWpGaD
Bumetanide—CA12—Metabolism—CAT—epilepsy syndrome	4.22e-06	6.64e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.21e-06	6.63e-05	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	4.21e-06	6.63e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ADSL—epilepsy syndrome	4.19e-06	6.61e-05	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—AVP—epilepsy syndrome	4.19e-06	6.6e-05	CbGpPWpGaD
Bumetanide—SLC22A6—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	4.17e-06	6.56e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—SLC2A1—epilepsy syndrome	4.14e-06	6.52e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CYP2C19—epilepsy syndrome	4.13e-06	6.5e-05	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—GPX1—epilepsy syndrome	4.12e-06	6.48e-05	CbGpPWpGaD
Bumetanide—CA7—Metabolism—GPX1—epilepsy syndrome	4.12e-06	6.48e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GLUL—epilepsy syndrome	4.11e-06	6.48e-05	CbGpPWpGaD
Bumetanide—CA12—Metabolism—ABCB1—epilepsy syndrome	4.1e-06	6.46e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CYP11A1—epilepsy syndrome	4.1e-06	6.46e-05	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—IL1B—epilepsy syndrome	4.1e-06	6.46e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—QDPR—epilepsy syndrome	4.1e-06	6.46e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CA4—epilepsy syndrome	4.1e-06	6.46e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PLCB1—epilepsy syndrome	4.1e-06	6.45e-05	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—CASP3—epilepsy syndrome	4.09e-06	6.44e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—TH—epilepsy syndrome	4.08e-06	6.43e-05	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	4.06e-06	6.39e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CACNA1D—epilepsy syndrome	4.04e-06	6.36e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—STX1B—epilepsy syndrome	3.99e-06	6.29e-05	CbGpPWpGaD
Bumetanide—CA14—Metabolism—AGT—epilepsy syndrome	3.97e-06	6.25e-05	CbGpPWpGaD
Bumetanide—CA14—Metabolism—APOE—epilepsy syndrome	3.89e-06	6.12e-05	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—MMP9—epilepsy syndrome	3.87e-06	6.09e-05	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—AGT—epilepsy syndrome	3.87e-06	6.09e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—COX3—epilepsy syndrome	3.85e-06	6.07e-05	CbGpPWpGaD
Bumetanide—CA12—Metabolism—GPX1—epilepsy syndrome	3.81e-06	6e-05	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—APOE—epilepsy syndrome	3.79e-06	5.96e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—TXNRD1—epilepsy syndrome	3.78e-06	5.95e-05	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—TNF—epilepsy syndrome	3.76e-06	5.92e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	3.75e-06	5.91e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3.72e-06	5.86e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CPSF4—epilepsy syndrome	3.71e-06	5.84e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—GBE1—epilepsy syndrome	3.71e-06	5.84e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PPP1R3C—epilepsy syndrome	3.71e-06	5.84e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CYP2D6—epilepsy syndrome	3.7e-06	5.83e-05	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	3.68e-06	5.79e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—AQP1—epilepsy syndrome	3.67e-06	5.77e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—KCNB1—epilepsy syndrome	3.65e-06	5.75e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CACNA2D2—epilepsy syndrome	3.65e-06	5.75e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SLCO1A2—epilepsy syndrome	3.65e-06	5.75e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PFKL—epilepsy syndrome	3.65e-06	5.75e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SLC6A8—epilepsy syndrome	3.65e-06	5.75e-05	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—AGT—epilepsy syndrome	3.61e-06	5.68e-05	CbGpPWpGaD
Bumetanide—CA7—Metabolism—AGT—epilepsy syndrome	3.61e-06	5.68e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	3.6e-06	5.67e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—HMOX1—epilepsy syndrome	3.57e-06	5.62e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	3.57e-06	5.62e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	3.55e-06	5.59e-05	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—APOE—epilepsy syndrome	3.54e-06	5.57e-05	CbGpPWpGaD
Bumetanide—CA7—Metabolism—APOE—epilepsy syndrome	3.54e-06	5.57e-05	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	3.53e-06	5.55e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CAT—epilepsy syndrome	3.52e-06	5.55e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ADRA2A—epilepsy syndrome	3.52e-06	5.55e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.52e-06	5.55e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—BCHE—epilepsy syndrome	3.51e-06	5.53e-05	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3.5e-06	5.5e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—ABCB1—epilepsy syndrome	3.43e-06	5.4e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—HMOX1—epilepsy syndrome	3.41e-06	5.37e-05	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	3.39e-06	5.33e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CAT—epilepsy syndrome	3.36e-06	5.29e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—SLC2A1—epilepsy syndrome	3.35e-06	5.27e-05	CbGpPWpGaD
Bumetanide—CA12—Metabolism—AGT—epilepsy syndrome	3.34e-06	5.26e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ATIC—epilepsy syndrome	3.34e-06	5.26e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—UPB1—epilepsy syndrome	3.34e-06	5.26e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—NEU1—epilepsy syndrome	3.34e-06	5.26e-05	CbGpPWpGaD
Bumetanide—CA14—Metabolism—POMC—epilepsy syndrome	3.34e-06	5.26e-05	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.33e-06	5.24e-05	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	3.32e-06	5.23e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CHRM3—epilepsy syndrome	3.32e-06	5.22e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—KCNJ11—epilepsy syndrome	3.32e-06	5.22e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PLCB1—epilepsy syndrome	3.31e-06	5.21e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—TH—epilepsy syndrome	3.3e-06	5.2e-05	CbGpPWpGaD
Bumetanide—CA12—Metabolism—APOE—epilepsy syndrome	3.28e-06	5.16e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—ABCB1—epilepsy syndrome	3.27e-06	5.15e-05	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—POMC—epilepsy syndrome	3.25e-06	5.12e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—HSD17B4—epilepsy syndrome	3.22e-06	5.07e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—GPX1—epilepsy syndrome	3.19e-06	5.02e-05	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	3.16e-06	4.97e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PPP1R3C—epilepsy syndrome	3.11e-06	4.89e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GBE1—epilepsy syndrome	3.11e-06	4.89e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.09e-06	4.86e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ST3GAL3—epilepsy syndrome	3.09e-06	4.86e-05	CbGpPWpGaD
Bumetanide—CA14—Metabolism—ALB—epilepsy syndrome	3.04e-06	4.79e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—GPX1—epilepsy syndrome	3.04e-06	4.79e-05	CbGpPWpGaD
Bumetanide—CA7—Metabolism—POMC—epilepsy syndrome	3.04e-06	4.78e-05	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—POMC—epilepsy syndrome	3.04e-06	4.78e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	3.04e-06	4.78e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.03e-06	4.76e-05	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.02e-06	4.75e-05	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—TNF—epilepsy syndrome	2.98e-06	4.69e-05	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—ALB—epilepsy syndrome	2.97e-06	4.67e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ASAH1—epilepsy syndrome	2.92e-06	4.6e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—STXBP1—epilepsy syndrome	2.84e-06	4.48e-05	CbGpPWpGaD
Bumetanide—CA12—Metabolism—POMC—epilepsy syndrome	2.81e-06	4.43e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—AGT—epilepsy syndrome	2.79e-06	4.4e-05	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	2.78e-06	4.38e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—NT5E—epilepsy syndrome	2.77e-06	4.36e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ALAD—epilepsy syndrome	2.77e-06	4.36e-05	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—ALB—epilepsy syndrome	2.77e-06	4.36e-05	CbGpPWpGaD
Bumetanide—CA7—Metabolism—ALB—epilepsy syndrome	2.77e-06	4.36e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—HMOX1—epilepsy syndrome	2.75e-06	4.34e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—APOE—epilepsy syndrome	2.74e-06	4.31e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CAT—epilepsy syndrome	2.72e-06	4.28e-05	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	2.7e-06	4.26e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ABCG2—epilepsy syndrome	2.7e-06	4.26e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—AGT—epilepsy syndrome	2.67e-06	4.2e-05	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PTGS2—epilepsy syndrome	2.66e-06	4.19e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ABCB1—epilepsy syndrome	2.64e-06	4.16e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CACNA1A—epilepsy syndrome	2.64e-06	4.16e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ALDH7A1—epilepsy syndrome	2.64e-06	4.16e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CYP2C19—epilepsy syndrome	2.63e-06	4.15e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CYP11A1—epilepsy syndrome	2.62e-06	4.12e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—APOE—epilepsy syndrome	2.61e-06	4.11e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.6e-06	4.09e-05	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PTGS2—epilepsy syndrome	2.6e-06	4.09e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ST3GAL3—epilepsy syndrome	2.59e-06	4.07e-05	CbGpPWpGaD
Bumetanide—CA12—Metabolism—ALB—epilepsy syndrome	2.57e-06	4.04e-05	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.54e-06	4e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ADSL—epilepsy syndrome	2.53e-06	3.99e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GLUL—epilepsy syndrome	2.48e-06	3.91e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GPX1—epilepsy syndrome	2.46e-06	3.87e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CACNA1D—epilepsy syndrome	2.44e-06	3.84e-05	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	2.42e-06	3.82e-05	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PTGS2—epilepsy syndrome	2.42e-06	3.82e-05	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PTGS2—epilepsy syndrome	2.42e-06	3.82e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.37e-06	3.73e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CYP2D6—epilepsy syndrome	2.36e-06	3.72e-05	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	2.36e-06	3.72e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—POMC—epilepsy syndrome	2.35e-06	3.7e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—TXNRD1—epilepsy syndrome	2.28e-06	3.59e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.25e-06	3.55e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ADRA2A—epilepsy syndrome	2.25e-06	3.54e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—EIF2AK2—epilepsy syndrome	2.25e-06	3.54e-05	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PTGS2—epilepsy syndrome	2.24e-06	3.53e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—POMC—epilepsy syndrome	2.24e-06	3.53e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—BCHE—epilepsy syndrome	2.24e-06	3.53e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—AQP1—epilepsy syndrome	2.21e-06	3.49e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—AGT—epilepsy syndrome	2.15e-06	3.39e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—ALB—epilepsy syndrome	2.14e-06	3.38e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—SLC2A1—epilepsy syndrome	2.14e-06	3.36e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.13e-06	3.35e-05	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.12e-06	3.33e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PLCB1—epilepsy syndrome	2.11e-06	3.33e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—APOE—epilepsy syndrome	2.11e-06	3.32e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—TH—epilepsy syndrome	2.11e-06	3.32e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PPIA—epilepsy syndrome	2.08e-06	3.28e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.07e-06	3.26e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—ALB—epilepsy syndrome	2.05e-06	3.22e-05	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	2.02e-06	3.19e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—KCNJ11—epilepsy syndrome	2e-06	3.15e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CHRM3—epilepsy syndrome	2e-06	3.15e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PTGS2—epilepsy syndrome	1.88e-06	2.95e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.86e-06	2.94e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.83e-06	2.88e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—POMC—epilepsy syndrome	1.81e-06	2.86e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PTGS2—epilepsy syndrome	1.79e-06	2.82e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—HMOX1—epilepsy syndrome	1.76e-06	2.77e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CAT—epilepsy syndrome	1.73e-06	2.73e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ABCB1—epilepsy syndrome	1.69e-06	2.66e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ALB—epilepsy syndrome	1.65e-06	2.6e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ABCG2—epilepsy syndrome	1.63e-06	2.57e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CYP2C19—epilepsy syndrome	1.59e-06	2.5e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CYP11A1—epilepsy syndrome	1.58e-06	2.49e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.57e-06	2.47e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GPX1—epilepsy syndrome	1.57e-06	2.47e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SLC2A1—epilepsy syndrome	1.54e-06	2.43e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—JUNB—epilepsy syndrome	1.53e-06	2.41e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NOS1—epilepsy syndrome	1.52e-06	2.39e-05	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.51e-06	2.37e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HBEGF—epilepsy syndrome	1.45e-06	2.28e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PTGS2—epilepsy syndrome	1.45e-06	2.28e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.43e-06	2.25e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CYP2D6—epilepsy syndrome	1.43e-06	2.25e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—AKT3—epilepsy syndrome	1.42e-06	2.24e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ADAM10—epilepsy syndrome	1.39e-06	2.19e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—AGT—epilepsy syndrome	1.38e-06	2.17e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ADRA2A—epilepsy syndrome	1.36e-06	2.14e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—BCHE—epilepsy syndrome	1.35e-06	2.13e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—APOE—epilepsy syndrome	1.35e-06	2.12e-05	CbGpPWpGaD
Bumetanide—CA14—Metabolism—AKT1—epilepsy syndrome	1.34e-06	2.11e-05	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—AKT1—epilepsy syndrome	1.3e-06	2.05e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CDC42—epilepsy syndrome	1.3e-06	2.04e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SLC2A1—epilepsy syndrome	1.29e-06	2.03e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PLCB1—epilepsy syndrome	1.28e-06	2.01e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—TH—epilepsy syndrome	1.27e-06	2e-05	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—AKT1—epilepsy syndrome	1.22e-06	1.92e-05	CbGpPWpGaD
Bumetanide—CA7—Metabolism—AKT1—epilepsy syndrome	1.22e-06	1.92e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HES1—epilepsy syndrome	1.19e-06	1.87e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—POMC—epilepsy syndrome	1.16e-06	1.82e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—FYN—epilepsy syndrome	1.15e-06	1.82e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—H2AFX—epilepsy syndrome	1.15e-06	1.81e-05	CbGpPWpGaD
Bumetanide—CA12—Metabolism—AKT1—epilepsy syndrome	1.13e-06	1.78e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—YWHAZ—epilepsy syndrome	1.11e-06	1.75e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CCR5—epilepsy syndrome	1.07e-06	1.68e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—HMOX1—epilepsy syndrome	1.06e-06	1.67e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ALB—epilepsy syndrome	1.06e-06	1.66e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CAT—epilepsy syndrome	1.05e-06	1.65e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ABCB1—epilepsy syndrome	1.02e-06	1.6e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—TSC2—epilepsy syndrome	9.93e-07	1.56e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—APOE—epilepsy syndrome	9.72e-07	1.53e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GPX1—epilepsy syndrome	9.47e-07	1.49e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—AKT1—epilepsy syndrome	9.43e-07	1.49e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PTGS2—epilepsy syndrome	9.23e-07	1.45e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—IL6ST—epilepsy syndrome	9.13e-07	1.44e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NOS2—epilepsy syndrome	9.05e-07	1.43e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—AKT1—epilepsy syndrome	9e-07	1.42e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—AGT—epilepsy syndrome	8.3e-07	1.31e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—APOE—epilepsy syndrome	8.14e-07	1.28e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—FGF2—epilepsy syndrome	7.38e-07	1.16e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—AKT1—epilepsy syndrome	7.27e-07	1.14e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—POMC—epilepsy syndrome	6.99e-07	1.1e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MTOR—epilepsy syndrome	6.72e-07	1.06e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ALB—epilepsy syndrome	6.37e-07	1e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SRC—epilepsy syndrome	5.38e-07	8.48e-06	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—AKT1—epilepsy syndrome	4.64e-07	7.31e-06	CbGpPWpGaD
Bumetanide—PTGS2—Disease—AKT1—epilepsy syndrome	3.35e-07	5.27e-06	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—AKT1—epilepsy syndrome	2.8e-07	4.41e-06	CbGpPWpGaD
